![]() |
市场调查报告书
商品编码
1930083
全球脑健康补充品市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察以及未来预测(2026-2034)Brain Health Supplements Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
随着人们对认知健康、心理健康和与年龄相关的神经系统疾病的关注度不断提高,全球脑健康补充品市场持续稳定成长。根据 Fortune Business Insights 预测,脑健康补充剂市场规模在2025年达到 67.4亿美元,并预计将在2026年成长至 72.4亿美元。在老年人和年轻人群体接受度不断提高的推动下,该市场预计将在2026年至2034年间以 8.00%的年复合成长率成长,到2034年达到 136.9亿美元。
北美在2025年占据全球市场主导地位,市场占有率为 48.86%,这主要得益于人们对认知障碍的高度关注、强大的购买力以及对用于心理健康的膳食补充剂的广泛接受。
市场概览
脑健康补充品是指目的是维持认知功能、记忆力、专注力和思考清晰度的补充品。这些补充剂通常含有维生素、矿物质、植物萃取物和促智成分,有助于维持大脑功能。人口老化、饮食相关慢性疾病盛行率上升以及认知障碍和阿兹海默症发病率增加是推动市场成长的关键因素。
此外,遵循限制性或特殊饮食的人群以及慢性病患者也日益选择服用这些补充剂来维护整体大脑健康。
新冠疫情的影响
新冠疫情加速了人们对心理健康、压力、焦虑和情绪健康的讨论,对脑部健康补充剂市场产生了积极影响。疫情封锁期间,人们面临的心理健康挑战日益增多,这提升了消费者对支持认知功能和情绪平衡的补充剂的兴趣。此外,疫情也促使人们更加重视预防保健和生活品质,推动了对脑部健康补充剂的需求。
在此期间,策略行销活动以及与心理健康支援组织的合作进一步提高了产品的知名度。
脑健康补充品市场趋势
新型膳食成分的引进
製造商正致力于引进新的、经科学验证的营养成分,以增强脑健康补充剂的安全性和有效性。新成分获得监管部门批准,有助于企业拓展产品组合,并增强消费者信任。
例如,2023年8月,AKER BIOMARINE的营养成分 "LYSOVETA" 获得美国FDA批准,有助于改善与年龄相关的认知衰退。此类批准在推动市场创新和普及方面发挥着重要作用。
市场成长因素
产品组合的拓展与新进者的涌入
年轻人心理健康意识的提高减少对认知障碍的歧视,并促进积极的健康管理。这种转变推动新进业者、自有品牌製造商和投资者进入市场。对含有天然成分的膳食补充剂的需求进一步加速了市场准入。
此外,代工生产的广泛普及也使得新兴品牌更容易以具有竞争力的价格推出脑部健康补充品产品。
运动产业的日益普及
体育产业正逐渐成为脑部健康补充品的重要消费族群。运动员越来越意识到营养在提高专注力、反应速度和心理耐力方面的重要作用。运动营养产品添加促智成分,以支持认知能力和整体运动表现。
补充剂生产商与体育组织之间的合作也进一步推动了市场需求。
限制因子
儘管需求不断成长,但市场仍面临诸多挑战,例如产品成本高、部分补充剂缺乏临床证据以及消费者和医疗专业人员的认知度较低。对副作用的担忧、使用未经批准的成分以及标籤不一致等问题也限制了它们在某些地区的普及。
此外,低收入国家缺乏经济能力也是市场渗透的障碍。
依产品类型
依产品类型划分,市场分为益智补充剂和维生素及矿物质补充剂。
预计到2026年,维生素及矿物质补充剂将占据79.05%的市场占有率,这主要得益于其在所有年龄层中的受欢迎程度以及消费者对必需营养素的强烈信任。
由于对认知增强产品的需求不断成长,预计益智补充剂将实现最快的成长速度。
依剂型
依剂型划分,市场包括锭剂、胶囊和其他剂型。
2026年,胶囊剂型将占据市场主导地位,市场占有率高达69.40%,这主要得益于其服用方便、清洁标籤的吸引力以及配方的灵活性。
依应用领域划分
依应用领域划分,市场可分为认知功能、压力/焦虑及其他领域。
2026年,压力/焦虑领域将以45.43%的市场占有率领跑,反映出全球心理压力水准的上升。
依通路划分
医院药局、药局/零售药局、线上通路和其他通路构成了分销结构。
2026年,医院药局将占据43.75%的市场占有率,但由于线上通路的便利性和可近性,预计将快速成长。
北美地区在2025年和2026年仍将保持领先地位,这主要得益于神经系统疾病的高诊断率和消费者对营养补充剂的强劲支出。
欧洲地区将以技术进步和认知功能监测工具维持较大的市场占有率。
亚太地区预计将强劲成长,这主要得益于电子商务平台的扩张和新兴经济体消费者意识的提高。
The global brain health supplements market is gaining steady momentum as awareness of cognitive health, mental wellness, and age-related neurological conditions continues to rise worldwide. According to Fortune Business Insights, the brain health supplements market was valued at USD 6.74 billion in 2025 and is projected to grow to USD 7.24 billion in 2026. Supported by increasing adoption among aging populations and younger consumers alike, the market is forecast to reach USD 13.69 billion by 2034, expanding at a CAGR of 8.00% during the 2026-2034 forecast period.
North America dominated the global market with a 48.86% share in 2025, driven by high awareness of cognitive disorders, strong purchasing power, and widespread acceptance of dietary supplements for mental wellness.
Market Overview
Brain health supplements are dietary products designed to support cognitive function, memory, focus, and mental clarity. These supplements typically contain vitamins, minerals, botanical extracts, and nootropic ingredients that assist in maintaining brain performance. The rising aging population, increasing prevalence of diet-related chronic diseases, and growing incidence of cognitive impairment and Alzheimer's disease are major factors supporting market growth.
In addition, individuals following restricted or specialized diets and people managing chronic medical conditions are increasingly adopting these supplements to support overall brain health.
Impact of COVID-19
The COVID-19 pandemic positively impacted the brain health supplements market by accelerating conversations around mental health, stress, anxiety, and emotional well-being. Increased exposure to mental health challenges during lockdowns led to higher consumer interest in supplements supporting cognitive performance and mood balance. Moreover, the pandemic encouraged individuals to prioritize preventive healthcare and quality of life, boosting demand for brain health supplements.
Strategic marketing campaigns and collaborations with mental health advocates further enhanced product visibility during this period.
Brain Health Supplements Market Trends
Introduction of New Dietary Ingredients
Manufacturers are increasingly focusing on introducing novel, scientifically backed dietary ingredients to improve the safety and efficacy of brain health supplements. Regulatory approvals for new ingredients are enabling companies to expand their product portfolios and strengthen consumer trust.
For instance, in August 2023, AKER BIOMARINE received U.S. FDA approval for LYSOVETA, a dietary ingredient designed to support cognitive decline during aging. Such approvals play a critical role in driving innovation and adoption in the market.
Market Growth Factors
Expansion of Product Portfolios and New Market Entrants
Growing awareness of mental health among younger populations has reduced stigma around cognitive disorders and encouraged proactive health management. This shift has attracted new entrants, private-label manufacturers, and investors into the market. Demand for supplements containing naturally sourced ingredients is further accelerating market entry.
In addition, the availability of contract manufacturing services has made it easier for emerging brands to launch brain health supplement products at competitive prices.
Rising Adoption in the Sports Industry
The sports industry is emerging as an important consumer segment for brain health supplements. Athletes increasingly recognize the role of nutrition in enhancing focus, reaction time, and mental endurance. Nootropic ingredients are being incorporated into sports nutrition products to support cognitive performance and overall athletic outcomes.
Collaborations between supplement manufacturers and sports organizations are further supporting market demand.
Restraining Factors
Despite growing demand, the market faces challenges such as high product costs, limited clinical evidence for some supplements, and lack of awareness among consumers and healthcare professionals. Concerns regarding side effects, unapproved ingredients, and inconsistent labeling also restrict adoption in certain regions.
Additionally, limited affordability in low-income countries acts as a barrier to widespread market penetration.
By Product Type
The market is segmented into nootropic supplements and vitamins & minerals.
The vitamins & minerals segment accounted for a dominant 79.05% market share in 2026, driven by widespread use across all age groups and strong consumer trust in essential nutrients.
Nootropic supplements are projected to grow at the fastest rate due to increasing demand for cognitive enhancement products.
By Dosage Form
Based on dosage form, the market includes tablets, capsules, and others.
The capsules segment dominated with a 69.40% share in 2026, supported by ease of consumption, clean-label appeal, and formulation flexibility.
By Application
The market is segmented into cognitive function, stress & anxiety, and others.
The stress & anxiety segment led the market with a 45.43% share in 2026, reflecting rising mental stress levels globally.
By Distribution Channel
Hospital pharmacies, drug stores & retail pharmacies, online channels, and others form the distribution landscape.
Hospital pharmacies accounted for a 43.75% share in 2026, while online channels are expected to grow rapidly due to convenience and accessibility.
North America remained the leading region in 2025 and 2026, supported by high diagnosis rates of neurological disorders and strong consumer spending on supplements.
Europe held a substantial share due to technological advancements and cognitive monitoring tools.
Asia Pacific is expected to witness strong growth driven by expanding e-commerce platforms and rising awareness in emerging economies.
Competitive Landscape
The market is fragmented, with companies focusing on new product launches, collaborations, and brand expansion. Key players include Reckitt Benckiser Group PLC, Natrol LLC, Neurohacker Collective, Onnit Labs, and Natural Factors USA, among others.
Conclusion
The global brain health supplements market, valued at USD 6.74 billion in 2025, increased to USD 7.24 billion in 2026 and is projected to reach USD 13.69 billion by 2034. Market growth is supported by rising awareness of cognitive health, increasing adoption across age groups, product innovation, and expanding distribution channels.
Segmentation By Product Type
By Dosage Form
By Application
By Distribution Channel
By Region